Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease

NCT05998824 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05998824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05998824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
September 19, 2023
Completion date
September 30, 2024
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccine, sickle cell disease, vaccine hesitancy